Outer-membrane proteins pattern and detection of β-lactamases in clinical isolates of imipenem-resistant Acinetobacter baumannii from Brazil

International Journal of Antimicrobial Agents

Volumn 13, Issue 3, 2000, Pages 175-182

  Costa, S F ^a   Woodcock, J ^b   Gill, M ^b   Wise, R ^b   Barone, A A ^a   Caiaffa, H ^a   Levin, A S S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b CITY HOSPITAL   (United Kingdom)

Author keywords

Acinetobacter baumannii; Imipenem; Resistance

Indexed keywords

AZTREONAM; BACTERIAL DNA; BETA LACTAMASE; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; OUTER MEMBRANE PROTEIN; POLYMYXIN; RIFAMPICIN; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ISOELECTRIC FOCUSING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; RIBOTYPING;

ACINETOBACTER; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BRAZIL; CHROMOSOMES, BACTERIAL; COLONY COUNT, MICROBIAL; DNA, RIBOSOMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; IMIPENEM; ISOELECTRIC FOCUSING; MALE; MICROBIAL SENSITIVITY TESTS; PLASMIDS; THIENAMYCINS;

EID: 0033991475     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00123-5     Document Type: Article

References (37)

1. Beck-Saguê C.M., Jarvis W.R., Brook J.H. et al. Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units. Am. J. Epidemiol. 22:1990;723-733.
2. Bergogne-Bérézin E. The increasing significance of outbreaks of Acinetobacter spp: the need for control and new agents. J. Hosp. Infect. 30:1995;441-452.
3. Koeleman J.G., Parlevliet G.A., Dijshoorn L., Savelkoul P.H., Vandenbrovcke C.M. Nosocomial outbreak of multi-resistant Acinetobacter baumannii on a surgical ward: epidemiology and risk factors for acquisition. J. Hosp. Infect. 2:1997;113-123.
4. Gerner-Smidt P. Acinetobacter in Denmark: II. molecular studies of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex. APMIS. 101:1993;826-832.
5. Gerner-Smidt P. Acinetobacter in Denmark: I. Taxonomy; antibiotic susceptibility and pathogenicity of 112 clinical strains. APMIS. 101:1993;815-825.
6. Ling MJ, NG TKC, Cheng AF, Norrby R. Susceptibilities to 23 antimicrobial agents and β-lactamase production of blood culture isolates of Acinetobacter sp. in Hong Kong. Scand J Infect Dis 1996;101:21-25.
7. Perilli M., Felici A., Oratore A., Cornaglia G., Bonfiglio G., Rossolini G.M., Amicosante G. Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii. Antimicrob. Agents. Chemother. 40:1996;715-719.
8. Vila J., Marcos A., Marco F., Abdalla S. et al. In vitro antimicrobial production of β-lactamases. Aminoglycoside-modifying enzymes and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob. Agents. Chemother. 37:1993;138-141.
9. Go E. Clinical and molecular epidemiology of Acinetobacter baumannii sensitive only to polymyxin b sulbactam. Lancet. 344:1994;1329-1332.
10. Lortholary O. Nosocomial acquisition of multiresistant Acinetobacter baumannii. Risk factors and prognosis. Clin. Infect. Dis. 20:1995;790-796.
11. Perez A.N., Bonet I.G., Robledo E.H., Abascal R.D., Pious C.V. Metallo-β-lactamases in Acinetobacter calcoaceticus? Med. Sci. Res. 24:1996;315-317.
12. Sader H.S., Mendes C.F., Pignatari A.C., Pfaller M. Use of macrorestriction analysis to demonstrate Interhospital spread of mutilresistant Acinetobacter baumannii in São Paulo, Brazil. Clin. Infect. Dis. 23:1996;631-634.
13. Tankovic J. Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods. J. Clin. Microb. 32:1994;2677-2681.
14. Wood C. Infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J. Infect. Dis. 168:1993;160-163.
15. Obara M., Nakae T. Mechanisms of resistance to β-lactam antibiotics in Acinetobacter calcoaceticus. J. Antimicrob. Chemother. 28:1991;791-800.
16. Sato K., Nakae T. Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance. J. Antimicrob. Chemother. 28:1991;35-45.
17. Clark R.B. Imipenem resistance among Acinetobacter baumannii association with reduced expression of a 33-36 kDa outer membrane protein. J. Antimicrob. Chemoter. 38:1996;244-251.
18. Srikumar R., Li X., Poole K. Inner membrane efflux components are responsible for β-lactam specificity of multidrug efflux pumps in Pseudomonas aeruginosa. J. Bact. 179(24):1997;7875-7888.
19. Nakae T., Nakajima A., Toshihisa O., Saito K., Yoneyama H. Resistance to β-lactam antibiotics in Pseudomonas aeruginosa due to nterplay between the mexAB-oprM efflux pump and β-lactamase. Antimicrob. Agents. Chemother. 43(5):1999;1301-1303.
20. Gehrlein M., Leying H., Cullmann W., Wendt S., Opferkuch W. Imipenem resistance in Acinetobacter baumannii is due to altered penicillin-binding proteins. Chemotherapy. 37:1991;405-412.
21. Bush K., Jacoby G.A., Medeiros A.A. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents. Chemother. 39:1995;1211-1233.
22. Paton RH, Miles RS, Hood J, Amyes SGB. ARI: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents 1993;2:81-8.
23. Scaife W., Young H., Paton R., Amyes S.G.B. Transferable imipenem-resistance in Acinetobacter species from a clinical source. J. Antimicrob. Chemother. 36:1995;585-587.
24. Brown S., Bantar C., Hilary-kay Y., Amyes S.C.G. Limitation of Acinetobacter baumannii treatment by plasmid mediated carbapenemase ARI-2. Lancet. 351:1998;186-187.
25. Payne D.J. Metallo-β-lactamases a new therapeutic challenge. J. Med. Microb. 39:1993;93-99.
26. Hernandez S.L., Alarcon T., Lopez-Brea M. Crabapenem resistance mediated by beta-lactamase in clinical Isolates of Acinetobacter baumamannii imipenem resistant. Eur. J. Clin. Microbiol. Infect. Dis. 17:1998;282-285.
27. Afzal-Shah M., Livermore D.M. Worlwide emergence of carbapenem-resistant Acinetobacter spp. J. Antimicrob. Chemother. 41(5):1998;576-577.
28. BSAC Working Party. A guide to sensivity testing. J Antimicrob Chemother 1991;27, suppl D.
29. Tenover F, Katherine P, Carlson L. Plasmid Fingerprint of Gram-Negative Organisms. In: Insenberg, H. (Ed.) Clinical microbiology procedures Handbook. Washington DC; American Society for Microbiology, 1992.
30. Stull T. A broad spectrum probe for molecular epidemiology of bacteria: ribosomal RNA. J. Infect. Dis. 157:1988;280-286.
31. Guymo I.F., Walstad D.I., Starling P.F. Cell envelope alterations in antibiotic sensitive and resistant strains of Neisseria gonorrhoeae. Bacteriology. 136:1978;301-401.
32. Matthew M., Harris A.M., Marshall M.J., Ross G.W. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J. Gen. Microb. 88:1975;169-178.
33. Masuda G., Tomioka S., Hasegawa M. Detection of β-lactamase production by Gram-negative bacteria. J. Antibiotics. 29:1976;662-664.
34. Levin A.S., Mendes C.M.F., Sinto I.S. et al. An outbreak of multiresistant Acinetobacter baumannii in a University Hospital in São Paulo, Brazil. Infect. Control. Hosp. Epidemiol. 17:1996;366-368.
35. Mcgowan J.E. Antimicrobial resistance in Hospital organisms and its relation to antibiotic use. Rev. Infect. Dis. 5:1985;1033-1048.
36. Manrique E, Fitipalldi D, Costa SF et al. Antimicrobial susceptibility of 9 agents of Nosocomial Infection during 10 years (20.0095 strains). In: ICAAC, september 28-October 1, Toronto, Canada.
37. Levin AS, Barone AA, Penco J et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999;28:1008-11.